PRIA Logo™
115-hr-5568115th Congress

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

Sponsored By: Representative Pallone, Frank [D-NJ-6]

Unknown

Summary

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018 This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Pallone, Frank [D-NJ-6]

NJ • D

Cosponsors

  • Rep. Guthrie, Brett [R-KY-2]

    KY • R

    Sponsored 4/18/2018

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation